Europe
News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.
Merck KGaA buys Amptec for mRNA tech and Chimerix acquires Oncoceutics for cancer pipeline.
BioSpace spoke to executives from four companies about their expectations for the conference and the coming year.
Here’s a run-down of some of the most recent collaboration announcements this week.
Frank Nestle, Sanofi’s chief scientific officer and Global Head of Research, and Dietmar Berger, Sanofi’s chief medical officer and Global Head of Development, provided an overview of the company’s clinical activities and highlighted some assets that will be key revenue drives for the company.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
DBV announced official restructuring plan for keeping the company afloat.
The recalibration will also have workforce implications, including an overall workforce reduction of approximately 20% during Q1, 2021.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business.
SARS-CoV-2 has mutated into several strains. Most of them are not particularly different than the primary strains, but two, B.1.1.7, which was first observed in the U.K., and now 501.V2, which originated in South Africa, have virologists watching closely.
PRESS RELEASES